Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 201–300 of 1,013
Baglioni, S., Cantini, G., Poli, G., Francalanci, M., Squecco, R., Di Franco, A., Borgogni, E., Frontera, S., Nesi, G., Liotta, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036569 · Cited by 166
“1 mM dexamethasone, 50 mM ascorbate-2-phosphate, 10 mM b-glycerophosphate for 3 weeks [7,21].”
Activity of mesenchymal stem cells in therapies for chronic skin wound healing
Nuschke, A. (2014) · Organogenesis · doi:10.4161/org.27405 · Cited by 169
Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy
Pessina, A., Bonomi, A., Coccè, V., Invernici, G., Navone, S., Cavicchini, L., Sisto, F., Ferrari, M., Viganò, L., Locatelli, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028321 · Cited by 167
Katsara, O., Mahaira, L. G., Iliopoulou, E. G., Moustaki, A., Antsaklis, A., Loutradis, D., Stefanidis, K., Baxevanis, C. N., Papamichail, M., & Perez, S. A. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0280 · Cited by 170
“The major source of MSCs is the bone marrow (BM), but, in the last decade, MSCs have been isolated from many different sources (adipose tissue, umbilical cord blood, umbilical cord, etc.) [3].”
Kang, B.-J., Ryu, H.-H., Park, S. S., Koyama, Y., Kikuchi, M., Woo, H.-M., Kim, W. H., & Kweon, O.-K. (2012) · Journal of Veterinary Science · doi:10.4142/jvs.2012.13.3.299 · Cited by 173
“However, BM harvesting is a laborious and traumatic procedure, and the number and differentiation potential of the MSCs decrease with increasing age of the MSC donor [23].”
BackgroundAhn, S. Y., Chang, Y. S., Sung, S. I., & Park, W. S. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0219 · Cited by 170
Wang, Y., Niu, H., Li, L., Han, J., Liu, Z., Chu, M., Sha, X., & Zhao, J. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01862-x · Cited by 172
Anderson, P., Carrillo-Gálvez, A. B., García-Pérez, A., Cobo, M., & Martín, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076979 · Cited by 162
“Although CD105 is generally considered an important marker for MSCs [11,21] several reports have shown that its expression vary depending upon MSC source (bone marrow-, adipose tissue-, umbilical cord blood derived MSCs or placenta-derived MSCs), culture time in vitro and differentiation state [22–25].”
BackgroundBochev, I., Elmadjian, G., Kyurkchiev, D., Tzvetanov, L., Altankova, I., Tivchev, P., & Kyurkchiev, S. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.12.007 · Cited by 166
Kucerova, L., Matuskova, M., Pastorakova, A., Tyciakova, S., Jakubikova, J., Bohovic, R., Altanerova, V., & Altaner, C. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1239 · Cited by 171
Adipose‐derived mesenchymal stem cells and regenerative medicine
Konno, M., Hamabe, A., Hasegawa, S., Ogawa, H., Fukusumi, T., Nishikawa, S., Ohta, K., Kano, Y., Ozaki, M., Noguchi, Y., et al. (2013) · Development, Growth & Differentiation · doi:10.1111/dgd.12049 · Cited by 164
“These are attractive stem cell sources for clinical therapies (Kern et al. 2006).”
BackgroundTisato, V, Naresh, K., Girdlestone, J., Navarrete, C., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404847 · Cited by 169
Yoo, S.-W., Kim, S.-S., Lee, S.-Y., Lee, H.-S., Kim, H.-S., Lee, Y.-D., & Suh-Kim, H. (2008) · Experimental and Molecular Medicine · doi:10.3858/emm.2008.40.4.387 · Cited by 168
“MSCs can be isolated from various tissues including bone marrow, adipose tissue, umbilical cord blood (Wagner et al., 2005; Kern et al., 2006).”
BackgroundToupadakis, C. A., Wong, A., Genetos, D. C., Cheung, W. K., Borjesson, D. L., Ferraro, G. L., Galuppo, L. D., Leach, J. K., Owens, S. D., & Yellowley, C. E. (2010) · American Journal of Veterinary Research · doi:10.2460/ajvr.71.10.1237 · Cited by 166
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy
Li, J., Wu, Z., Zhao, L., Liu, Y., Su, Y., Gong, X., Liu, F., & Zhang, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03587-y · Cited by 150
“It has been shown that human umbilical cord perivascular cells (HUCPVCs) show a higher proliferative potential than BM-MSCs and are able to differentiate into bone, cartilage, and adipose, and in addition, HUCPVCs exhibit higher levels of CD146 relative to BM-MSCs [78].”
BackgroundAdipose Tissue-Derived Stem Cells and Their Application in Bone and Cartilage Tissue Engineering
Rada, T., Reis, R. L., & Gomes, M. E. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0423 · Cited by 164
Liu, F., Hu, S., Yang, H., Li, Z., Huang, K., Su, T., Wang, S., & Cheng, K. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900411 · Cited by 168
CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture
Álvarez-Viejo, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.470 · Cited by 163
Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors
Boeuf, S., & Richter, W. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt31 · Cited by 163
“Th e analysis of MSCs from BM, AT, SM and periosteum showed that these cells can be characterized by the absence of expression of surface markers for the haematopoietic lineage, such as the cluster of diff erentiation (CD) molecules CD14, CD31 or CD45, and by positivity for a panel of markers, including CD13, CD29, CD…”
BackgroundResultInfluentialHa, C.-W., Park, Y.-B., Kim, S. H., & Lee, H.-J. (2019) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2018.07.028 · Cited by 162
Abraham, A., & Krasnodembskaya, A. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0205 · Cited by 160
Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?
Lindner, U., Kramer, J., Rohwedel, J., & Schlenke, P. (2010) · Transfusion Medicine and Hemotherapy · doi:10.1159/000290897 · Cited by 151
Mammalian MSC from selected species: Features and applications
Uder, C., Brückner, S., Winkler, S., Tautenhahn, H., & Christ, B. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23239 · Cited by 161
Lui, P. P. Y., & Chan, K. M. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9276-0 · Cited by 163
“This has implications in the selection of an appropriate cell source and conditions for engineering of specific tissue type [122–131].”
BackgroundThe Current and Future Therapies of Bone Regeneration to Repair Bone Defects
Jimi, E., Hirata, S., Osawa, K., Terashita, M., Kitamura, C., & Fukushima, H. (2012) · International Journal of Dentistry · doi:10.1155/2012/148261 · Cited by 183
“MSCs constitute heterogeneous cell types, and the potential for proliferation and differentiation of the MSCs depends on a patient’s age, sex, or the presence of certain medical conditions, such as diabetes or hypertension [13].”
Barberini, D. J., Freitas, N. P. P., Magnoni, M. S., Maia, L., Listoni, A. J., Heckler, M. C. T., Sudano, M. J., Golim, M. D. A., Landim‐Alvarenga, F. D. C., & Amorim, R. M. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt414 · Cited by 166
Tyndall, A., Walker, U. A., Cope, A. P., Dazzi, F., Bari, C. D., Fibbe, W. E., Guiducci, S., Jones, S., Jørgensen, C., Blanc, K. L., et al. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2103 · Cited by 187
“similar to their BM-derived counterparts [65].”
de Girolamo, L., Lucarelli, E., Alessandri, G., Antonietta Avanzini, M., Ester Bernardo, M., Biagi, E., Teresa Brini, A., D’Amico, G., Fagioli, F., Ferrero, I., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130015 · Cited by 161
“It has been demonstrated that all cells isolated from adipose tissue, bone marrow and umbilical cord blood exhibit a similar fibroblastoid morphology, formation of CFU-F, multipotential differentiation capability and expression of a typical set of surface proteins, with the exception of CD105 and CD106, described to b…”
Shafiee, A., Seyedjafari, E., Soleimani, M., Ahmadbeigi, N., Dinarvand, P., & Ghaemi, N. (2011) · Biotechnology Letters · doi:10.1007/s10529-011-0541-8 · Cited by 163
“However, MSC isolated from adipose-tissue have shown an osteogenic differentiation potential less than those isolated from bone marrow (Kern et al. 2006).”
BackgroundResultMesenchymal Stem Cells – Sources and Clinical Applications
Klingemann, H., Matzilevich, D., & Marchand, J. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000142333 · Cited by 158
Ranera, B., Lyahyai, J., Romero, A., Vázquez, F. J., Remacha, A. R., Bernal, M. L., Zaragoza, P., Rodellar, C., & Martín‐Burriel, I. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.033 · Cited by 163
“Both popu- ell surface markers mmunophenotype ene expression lations of cells expressed CD13, CD29, CD44, CD49d, CD73, CD90, CD105, CD106, CD146 and CD166 transcripts.”
BackgroundResultInfluentialMechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells
Zhang, Y., Khan, D., Delling, J., & Tobiasch, E. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/793823 · Cited by 184
“the adipogenic lineage [38, 39].”
Zhang, H., Lau, D. H., Shlapakova, I. N., Zhao, X., Danilo, P., Robinson, R. B., Cohen, I. S., Qu, D., Xu, Z., & Rosen, M. R. (2011) · Cell Transplantation · doi:10.3727/096368911x565038 · Cited by 161
Adipose-derived stem cells: Effectiveness and advances in delivery in diabetic wound healing
Gadelkarim, M., Abushouk, A. I., Ghanem, E., Hamaad, A. M., Saad, A. M., & Abdel-Daim, M. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.013 · Cited by 158
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
Vija, L., Farge, D., Gautier, J.-F., Vexiau, P., Dumitrache, C., Bourgarit, A., Verrecchia, F., & Larghero, J. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.10.003 · Cited by 160
Growth factors and chondrogenic differentiation of mesenchymal stem cells
Danišovič, Ľ., Varga, I., & Polák, Š. (2011) · Tissue and Cell · doi:10.1016/j.tice.2011.11.005 · Cited by 160
Soltani, S. K., Forogh, B., Ahmadbeigi, N., Kharazi, H. H., Falahzadeh, K., Kashani, L., Karami, M., Kheyrollah, Y., & Vasei, M. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.11.003 · Cited by 167
Marolt, D., Traweger, A., Gimona, M., & Redl, H. R. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00352 · Cited by 175
“, 2019), involving both intra- as well as extra-cellular mechanisms, perinatal tissues and induced pluripotent stem cells have raised interest as potential sources of “young”MSCs with high regenerative properties (Kern et al., 2006; Baksh et al., 2007; Robey, 2011; De Peppo et al., 2013; Ghasemzadeh et al., 2018; Spit…”
BackgroundWright, A., Arthaud-Day, M. L., & Weiss, M. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.632717 · Cited by 150
“Hu et al. (2018) demonstrated that BM-MSCs from C57BL/6 mice expressed high levels of CD34 but lacked CD90 as well as noted slight strain differences in surface marker expression.”
BackgroundInfluentialCarrade, D. D., Owens, S. D., Galuppo, L. D., Vidal, M. A., Ferraro, G. L., Librach, F., Buerchler, S., Friedman, M. S., Walker, N. J., & Borjesson, D. L. (2010) · Cytotherapy · doi:10.3109/14653249.2010.536213 · Cited by 173
Rider, D. A., Dombrowski, C., Sawyer, A. A., Ng, G. H. B., Leong, D. T., Hutmacher, D. W., Nurcombe, V., & Cool, S. M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0480 · Cited by 163
Rehabilitation of Irradiated Head and Neck Tissues by Autologous Fat Transplantation
Phulpin, B., Gangloff, P., Tran, N., Bravetti, P., Merlin, J., & Dolivet, G. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31819f2928 · Cited by 157
Human Adipose-Derived Cells: An Update on the Transition to Clinical Translation
Gimble, J. M., Bunnell, B. A., & Guilak, F. (2012) · Regenerative Medicine · doi:10.2217/rme.11.119 · Cited by 168
Park, A., Hogan, M. V., Kesturu, G. S., James, R., Balian, G., & Chhabra, A. B. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0710 · Cited by 156
Arun Kumar, R., Sivashanmugam, A., Deepthi, S., Iseki, S., Chennazhi, K. P., Nair, S. V., & Jayakumar, R. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02685 · Cited by 153
Raicevic, G., Najar, M., Stamatopoulos, B., Bruyn, C. D., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.010 · Cited by 174
Cho, K., Park, H.-K., Park, H., Jung, J. S., Jeon, S. G., Kim, Y., & Roh, H. J. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0283 · Cited by 168
Lee, S., Park, J., Seo, M., Roh, K., Park, S., Hwang, J., Sun, B., Seo, K., Lee, Y., Kang, S., et al. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00633.x · Cited by 150
Stem cells derived from amniotic fluid: new potentials in regenerative medicine
Cananzi, M., Atala, A., & Coppi, P. D. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60111-3 · Cited by 163
“The harvest of bone marrow remains a highly invasive and painful procedure, and the number, proliferation and differentiation potential of these cells decline with increasing age (D’Ippolito et al., 1999; Kern et al., 2006).”
BackgroundAdipose-derived stem cells as a new therapeutic modality for ageing skin
Kim, J., Jung, M., Kim, H. S., Kim, Y., & Choi, E. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01221.x · Cited by 156
Inoue, T., Sugiyama, M., Hattori, H., Wakita, H., Wakabayashi, T., & Ueda, M. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0385 · Cited by 163
Marconi, S., Bonaconsa, M., Scambi, I., Squintani, G. M., Rui, W., Turano, E., Ungaro, D., D’Agostino, S., Barbieri, F., Angiari, S., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.034 · Cited by 157
“The comparative analysis of ASC and BM-MSC clearly showed that these two cell types do not differ regarding morphology, immune phenotype, success rate of cell isolation, colony frequency and differentiation capacity (Kern et al., 2006; Krampera et al., 2007).”
Azouna, N. B., Jenhani, F., Regaya, Z., Berraeis, L., Othman, T. B., Ducrocq, E., & Domenech, J. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt97 · Cited by 151
“Thereafter, MSCs have been described in virtually all post-natal organs or tissues [7] but also in fetal adnexa, including both umbilical cord blood [8,9] and placenta [7,10,11].”
BackgroundReinisch, A., Bartmann, C., Rohde, E., Schallmoser, K., Bjelic‐Radisic, V., Lanzer, G., Linkesch, W., & Strunk, D. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.4.371 · Cited by 158
“These include umbilical cord blood (UCB) [14–17], adipose tissue [18–20], umbilical cord [21–24], placenta [25] and amniotic fluid [26].”
BackgroundInfluentialCharacterization of clonogenic stromal cells isolated from human endometrium
Dimitrov, R., Timeva, T., Kyurkchiev, D., Stamenova, M., Shterev, A., Kostova, P., Zlatkov, V, Kehayov, I., & Kyurkchiev, S. (2008) · REPRODUCTION · doi:10.1530/rep-07-0428 · Cited by 152
“confluence, they were induced to undergo adipogenic differentiation following the protocol of Kern et al. (2006). Briefly, cells were grown in an adipogenic induction medium”
MethodMobasheri, A., Csaki, C., Clutterbuck, A. L., Rahmanzadeh, M., & Shakibaei, M. (2009) · PubMed · doi:10.14670/hh-24.347 · Cited by 168
“It has also been observed that human adipose tissue yields higher amounts of MSCs then bone marrow or umbilical cord blood (Kern et al., 2006).”
BackgroundFernández-Santos, M. E., Garcia-Arranz, M., Andreu, E. J., García-Hernández, A. M., López-Parra, M., Villarón, E., Sepúlveda, P., Fernández-Avilés, F., García-Olmo, D., Prosper, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918565 · Cited by 139
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
Zomer, H. D., Vidane, A. S., Gonçalves, N. N., & Ambrósio, C. E. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s88036 · Cited by 168
How do mesenchymal stromal cells exert their therapeutic benefit?
Horwitz, E., & Dominici, M. (2008) · Cytotherapy · doi:10.1080/14653240802618085 · Cited by 159
Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring
Resch, T., Cardini, B., Oberhuber, R., Weißenbacher, A., Dumfarth, J., Krapf, C., Boesmueller, C., Oefner, D., Grimm, M. F., & Schneeberger, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00631 · Cited by 151
Sharma, V., Srinivasan, A., Nikolajeff, F. K., & Kumar, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.049 · Cited by 158
Stem Cell-Based Clinical Trials for Diabetes Mellitus
de Klerk, E., & Hebrok, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.631463 · Cited by 157
“org 4 from almost all tissues that include a perivascular area (48, 49).”
BackgroundReview: Gene- and Stem Cell–Based Therapeutics for Bone Regeneration and Repair
Kimelman, N. B., Pelled, G., Helm, G. A., Huard, J., Schwarz, E. M., & Gazit, D. (2007) · Tissue Engineering · doi:10.1089/ten.2007.0096 · Cited by 165
Stromal vascular fraction improves deep partial thickness burn wound healing
Atalay, S., Çoruh, A., & Denız, K. (2014) · Burns · doi:10.1016/j.burns.2014.01.023 · Cited by 150
Wuchter, P., Bieback, K., Schrezenmeier, H., Bornhäuser, M., Müller, L. P., Bonig, H. B., Wagner, W., Meisel, R., Pavel, P., Tonn, T., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.04.002 · Cited by 159
Self-citationArmiñán, A., Gandía, C., Bartual, M., García‐Verdugo, J. M., Lledó, E., Mirabet, V., Llop-Miguel, M., Barea, J., Montero, J., & Sepúlveda, P. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0292 · Cited by 160
Carvalho, A. D. M., Alves, A. L. G., Golim, M. D. A., Moroz, A., Hussni, C. A., Oliveira, P. G. G., & Deffune, E. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.06.014 · Cited by 150
Yousefifard, M., Nasirinezhad, F., Shardi Manaheji, H., Janzadeh, A., Hosseini, M., & Keshavarz, M. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0295-2 · Cited by 146
Hakkarainen, T., Särkioja, M., Lehenkari, P., Miettinen, S., Ylikomi, T., Suuronen, R., Desmond, R. A., Kanerva, A., & Hemminki, A. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.034 · Cited by 146
“In fact, it has been suggested that there might be similarities between adipose- and bone marrow-derived MSCs both on biological and molecular levels (Izadpanah et al., 2006; Kern et al., 2006; Talens-Visconti et al., 2006).”
BackgroundBiomimetic Cell Culture Proteins as Extracellular Matrices for Stem Cell Differentiation
Higuchi, A., Ling, Q., Hsu, S.-T., & Umezawa, A. (2012) · Chemical Reviews · doi:10.1021/cr3000169 · Cited by 157
Noer, A., Sørensen, A. L., Boquest, A. C., & Collas, P. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-04-0322 · Cited by 159
Kim, M. J., Shin, K. S., Jeon, J. H., Lee, D. R., Shim, S. H., Kim, J. K., Cha, D. H., Yoon, T. K., & Kim, G. J. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1249-8 · Cited by 150
“Consistent with our results, the expression of the RNA component of human telomerase has previously been detected in the chorion and does not correlate with telomerase activity (Kyo et al. 1997).”
ResultAdipose Tissue-Derived Cells Improve Cardiac Function Following Myocardial Infarction
Schenke‐Layland, K., Strem, B. M., Jordan, M. C., DeEmedio, M. T., Hedrick, M. H., Roos, K. P., Fraser, J. K., & MacLellan, W. R. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.03.019 · Cited by 157
“ADCs were further washed in sterile phosphate buffered saline (PBS; Invitrogen, Carlsbad, CA), counted and resuspended at 25 × 106 cells/ ml in saline for infusion into post MI rats, prepared for fluorescence activated cell sorter (FACS) analysis, or placed into low density culture for colony forming unit fibroblast (…”
MethodLi, P., & Guo, X. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1044-5 · Cited by 152
Gaebel, R., Furlani, D., Sorg, H., Polchow, B., Frank, J., Bieback, K., Wang, W., Klopsch, C., Ong, L.-L., Li, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015652 · Cited by 141
“Bieback and coworkers demonstrated that among different stem cell surface markers (CD29, 44, 73, 90, 105), CD105 was significantly lower expressed in CB-derived hMSC than in AT and BM [34].”
BackgroundMethodSelf-citationMartinello, T., Bronzini, I., Maccatrozzo, L., Mollo, A., Sampaolesi, M., Mascarello, F., Decaminada, M., & Patruno, M. (2010) · Research in Veterinary Science · doi:10.1016/j.rvsc.2010.07.024 · Cited by 170
“Numerous studies (Lee et al., 2004; Kern et al., 2006; Rebelatto et al., 2008) have demonstrated that human mesenchymal stem cells derived from adipose tissue (A-MSC) express classic MSC markers as CD90, CD44, CD73, CD105, CD117, CD106 and possess the same capacity of bone marrow-derived stem cells…”
BackgroundResultInfluentialNew therapeutic approaches of mesenchymal stem cells-derived exosomes
Janočková, J., Slovinská, L., Harvanová, D., Špaková, T., & Rosocha, J. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00736-4 · Cited by 160
Kornicka, K., Marycz, K., Tomaszewski, K. A., Marędziak, M., & Śmieszek, A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/309169 · Cited by 137
“Human ASCs, like BMSCs, are characterized by similar phenotype, stability over long term culture, and extended efficiency in vitro [13].”
BackgroundYamada, Y., Nakamura, S., Ito, K., Sugito, T., Yoshimi, R., Nagasaka, T., & Ueda, M. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0732 · Cited by 153
“16 Another promising source for stem cells is from dental pulp, a loose vascular connective tissue surrounded by dentine and consisting of a heterogeneous population of cells.”
Mesenchymal stem cells as a potential pool for cartilage tissue engineering
Csaki, C., Schneider, P. R. A., & Shakibaei, M. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2008.07.007 · Cited by 163
“The advantage over other methods of obtaining MSCs is that, for one, adipose tissue can be obtained by procedures that are minimal invasive and, MSCs yields obtained from adipose tissue are higher compared to other sources of MSCs such as bone marrow or umbilical cord blood (Helder et al., 2007; Kern et al., 2006).”
BackgroundResultInfluentialShin, H., Ryu, H. H., Kwon, O., Park, B., & Jo, S. J. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12650 · Cited by 142
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Buijsen, R. A. M., Toonen, L. J. A., Gardiner, S. L., & van Roon‐Mom, W. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00696-y · Cited by 152
Modeling sarcomagenesis using multipotent mesenchymal stem cells
Rodríguez, R., Rubio, R., & Menéndez, P. R. (2011) · Cell Research · doi:10.1038/cr.2011.157 · Cited by 149
Ryu, K., Cho, K., Park, H. S., Kim, J.-Y., Woo, S., Jo, I., Choi, Y. H., Park, Y. M., Jung, S., Chung, S. M., et al. (2012) · Cytotherapy · doi:10.3109/14653249.2012.706708 · Cited by 147
Blazejewska, E. A., Call, M. K., Yamanaka, O., Liu, H., Schlötzer-Schrehardt, U. M., Kruse, F. E., & Kao, W. W. ‐. (2011) · Stem Cells · doi:10.1002/stem.550 · Cited by 146
Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G. T., & Kassem, M. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.004 · Cited by 155
“Some, but not all of these characteristics have also been described for MSC cultures (Fehrer et al., 2007; Kern et al., 2006; Stenderup et al., 2003; Stenderup et al., 2004; Stolzing et al., 2008)”
BackgroundOñate, B., Vilahur, G., Ferrer‐Lorente, R., Ybarra, J., Díez‐Caballero, A., Ballesta‐López, C., Moscatiello, F., Herrero, J., & Badimon, L. (2012) · The FASEB Journal · doi:10.1096/fj.12-207217 · Cited by 138
Chen, L., Zhang, C., Chen, L., Wang, X., Xiang, B., Wu, X., Guo, Y., Mou, X., Yuan, L., Chen, B., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0265 · Cited by 140
Luo, G., Cheng, W., He, W., Wang, X., Tan, J., Fitzgerald, M., Li, X., & Wu, J. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00616.x · Cited by 137
Kim, S. M., Oh, J. H., Park, S. A., Ryu, C. H., Lim, J. Y., Kim, D.-S., Chang, J. W., Oh, W., & Jeun, S.-S. (2010) · Stem Cells · doi:10.1002/stem.543 · Cited by 136
Pendleton, C. A., Li, Q., Chesler, D. A., Yuan, K., Guerrero‐Cazares, H., & Quiñones‐Hinojosa, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058198 · Cited by 141
“Harvest efficiency for AMSCs and BMSCs partially depends on donor age [36]; the BMSC population has been shown to decrease substantially with age, casting further doubt on the use of autologous BMSCs as a therapeutic delivery vehicle in the patient population most often afflicted with gliomas [37].”
BackgroundKølle, S.-F. T., Oliveri, R. S., Glovinski, P. V., Elberg, J. J., Fischer‐Nielsen, A., & Drzewiecki, K. T. (2012) · Journal of Plastic Surgery and Hand Surgery · doi:10.3109/2000656x.2012.668326 · Cited by 141
Clinical grade adult stem cell banking
Thirumala, S., Goebel, W. S., & Woods, E. J. (2009) · Organogenesis · doi:10.4161/org.5.3.9811 · Cited by 148
“As compared to bone marrow, further reduced frequency of MSCs is reported for cord blood stem cells.(16,17) Gronthos et al.”
Bieback, K., Kern, S., Kocaömer, A., Ferlik, K., & Bugert, P. (2008) · PubMed · Cited by 162
Self-citationKim, H., Bae, C., Kook, Y.-M., Koh, W., Lee, K., & Park, M. H. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1130-8 · Cited by 147
Izadi, M., Nejad, A. S. H., Moazenchi, M., Masoumi, S., Rabbani, A., Kompani, F., Asl, A. A. H., Kakroodi, F. A., Jaroughi, N., Meybodi, M. A. M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02941-w · Cited by 148
“We selected bone marrow as the source of MSCs, as it is the most common source of MSCs for clinical trials and the first reported source of MSCs [49, 53].”
BackgroundThe multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Liu, W., Song, F., Ren, L., Guo, W., Wang, T., Feng, Y., Tang, L., & Li, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12482 · Cited by 139
“Generally speaking, there are no significant differences concerning the morphology and immune phenotype of the MSCs derived from these three sources [16].”
BackgroundGentile, P., Calabrese, C., Angelis, B. D., Pizzicannella, J., Kothari, A. S., & Garcovich, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215471 · Cited by 143
Mesenchymal Stem Cells for Vascular Regeneration
Huang, N. F., & Li, S. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.877 · Cited by 152
Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction
Francis, M. P., Sachs, P. C., Elmore, L. W., & Holt, S. E. (2010) · Organogenesis · doi:10.4161/org.6.1.10019 · Cited by 148
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.